
Daniel E. Kolker
Examiner (ID: 8774)
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1649, 1646, 1644, 1645 |
| Total Applications | 546 |
| Issued Applications | 177 |
| Pending Applications | 78 |
| Abandoned Applications | 291 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7024936
[patent_doc_number] => 20050019330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Prevention and treatment of amyloidogenic disease'
[patent_app_type] => utility
[patent_app_number] => 10/923469
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 32290
[patent_no_of_claims] => 163
[patent_no_of_ind_claims] => 62
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019330.pdf
[firstpage_image] =>[orig_patent_app_number] => 10923469
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/923469 | Prevention and treatment of amyloidogenic disease | Aug 19, 2004 | Issued |
Array
(
[id] => 7082669
[patent_doc_number] => 20050048049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Prevention and treatment of amyloidogenic disease'
[patent_app_type] => utility
[patent_app_number] => 10/923474
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 32271
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048049.pdf
[firstpage_image] =>[orig_patent_app_number] => 10923474
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/923474 | Prevention and treatment of amyloidogenic disease | Aug 19, 2004 | Abandoned |
Array
(
[id] => 5801286
[patent_doc_number] => 20060035826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Promotion of axonal regeneration'
[patent_app_type] => utility
[patent_app_number] => 10/917905
[patent_app_country] => US
[patent_app_date] => 2004-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16651
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035826.pdf
[firstpage_image] =>[orig_patent_app_number] => 10917905
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/917905 | Promotion of axonal regeneration | Aug 12, 2004 | Issued |
Array
(
[id] => 7251732
[patent_doc_number] => 20040259092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Nogo receptor homologues and their use'
[patent_app_type] => new
[patent_app_number] => 10/487886
[patent_app_country] => US
[patent_app_date] => 2004-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14789
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259092.pdf
[firstpage_image] =>[orig_patent_app_number] => 10487886
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/487886 | Nogo receptor homologues and their use | Aug 10, 2004 | Abandoned |
Array
(
[id] => 7800872
[patent_doc_number] => 08129142
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-06
[patent_title] => 'Mutations in ion channels'
[patent_app_type] => utility
[patent_app_number] => 10/567424
[patent_app_country] => US
[patent_app_date] => 2004-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 23369
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/129/08129142.pdf
[firstpage_image] =>[orig_patent_app_number] => 10567424
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/567424 | Mutations in ion channels | Aug 5, 2004 | Issued |
Array
(
[id] => 7178354
[patent_doc_number] => 20050124016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Antibodies specific for toxic amyloid beta protein oligomers'
[patent_app_type] => utility
[patent_app_number] => 10/909597
[patent_app_country] => US
[patent_app_date] => 2004-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13883
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20050124016.pdf
[firstpage_image] =>[orig_patent_app_number] => 10909597
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/909597 | Antibodies specific for toxic amyloid beta protein oligomers | Aug 1, 2004 | Abandoned |
Array
(
[id] => 7033622
[patent_doc_number] => 20050032131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases'
[patent_app_type] => utility
[patent_app_number] => 10/909116
[patent_app_country] => US
[patent_app_date] => 2004-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11078
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20050032131.pdf
[firstpage_image] =>[orig_patent_app_number] => 10909116
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/909116 | Isolated peptides to treat alpha-synuclein diseases | Jul 29, 2004 | Issued |
Array
(
[id] => 6971748
[patent_doc_number] => 20050037458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 10/805667
[patent_app_country] => US
[patent_app_date] => 2004-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 238
[patent_figures_cnt] => 238
[patent_no_of_words] => 146164
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10805667
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/805667 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Jul 22, 2004 | Abandoned |
Array
(
[id] => 442509
[patent_doc_number] => 07256003
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-14
[patent_title] => 'Method for differentiation of Alzheimer\'s Disease into subgroups'
[patent_app_type] => utility
[patent_app_number] => 10/890508
[patent_app_country] => US
[patent_app_date] => 2004-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3631
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/256/07256003.pdf
[firstpage_image] =>[orig_patent_app_number] => 10890508
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/890508 | Method for differentiation of Alzheimer's Disease into subgroups | Jul 12, 2004 | Issued |
Array
(
[id] => 7426669
[patent_doc_number] => 20040265799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Human-virus homologous sequences and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/873314
[patent_app_country] => US
[patent_app_date] => 2004-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22996
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20040265799.pdf
[firstpage_image] =>[orig_patent_app_number] => 10873314
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/873314 | Human-virus homologous sequences and uses thereof | Jun 22, 2004 | Abandoned |
Array
(
[id] => 5259621
[patent_doc_number] => 20070213253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Synuclein Mutant Having Aggregation-Inhibitory Activity'
[patent_app_type] => utility
[patent_app_number] => 10/562063
[patent_app_country] => US
[patent_app_date] => 2004-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4955
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20070213253.pdf
[firstpage_image] =>[orig_patent_app_number] => 10562063
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/562063 | Synuclein Mutant Having Aggregation-Inhibitory Activity | Jun 21, 2004 | Abandoned |
Array
(
[id] => 7055633
[patent_doc_number] => 20050276806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-15
[patent_title] => 'Treatment of autism'
[patent_app_type] => utility
[patent_app_number] => 10/868140
[patent_app_country] => US
[patent_app_date] => 2004-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26065
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20050276806.pdf
[firstpage_image] =>[orig_patent_app_number] => 10868140
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/868140 | Treatment of autism | Jun 14, 2004 | Abandoned |
Array
(
[id] => 5182971
[patent_doc_number] => 20070054318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Soluble low-density lipoprotein receptor related protein binds directly to alzheimer\'s amyloid-beta peptide'
[patent_app_type] => utility
[patent_app_number] => 10/558984
[patent_app_country] => US
[patent_app_date] => 2004-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13725
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20070054318.pdf
[firstpage_image] =>[orig_patent_app_number] => 10558984
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/558984 | Soluble low-density lipoprotein receptor related protein binds directly to Alzheimer's amyloid-beta peptide | Jun 13, 2004 | Issued |
Array
(
[id] => 7317598
[patent_doc_number] => 20040224365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Fluorescent amyloid Abeta peptides and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/864107
[patent_app_country] => US
[patent_app_date] => 2004-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8449
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224365.pdf
[firstpage_image] =>[orig_patent_app_number] => 10864107
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/864107 | Fluorescent amyloid Abeta peptides and uses thereof | Jun 8, 2004 | Abandoned |
Array
(
[id] => 7318854
[patent_doc_number] => 20040224894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Methods and use of motoneuronotrophic factor'
[patent_app_type] => new
[patent_app_number] => 10/858545
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 12624
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224894.pdf
[firstpage_image] =>[orig_patent_app_number] => 10858545
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/858545 | Methods and use of motoneuronotrophic factor | May 31, 2004 | Abandoned |
Array
(
[id] => 7434241
[patent_doc_number] => 20040266691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Methods and use of motoneuronotrophic factor'
[patent_app_type] => new
[patent_app_number] => 10/858543
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 12622
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266691.pdf
[firstpage_image] =>[orig_patent_app_number] => 10858543
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/858543 | Methods and use of motoneuronotrophic factor | May 31, 2004 | Abandoned |
Array
(
[id] => 7264950
[patent_doc_number] => 20040242486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Methods and use of motoneuronotrophic factor'
[patent_app_type] => new
[patent_app_number] => 10/858286
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 12641
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242486.pdf
[firstpage_image] =>[orig_patent_app_number] => 10858286
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/858286 | Methods and use of motoneuronotrophic factor | May 31, 2004 | Abandoned |
Array
(
[id] => 7341122
[patent_doc_number] => 20040191171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Method of detecting skin stimulation effect'
[patent_app_type] => new
[patent_app_number] => 10/480784
[patent_app_country] => US
[patent_app_date] => 2004-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4898
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20040191171.pdf
[firstpage_image] =>[orig_patent_app_number] => 10480784
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/480784 | Method of detecting skin stimulation effect | May 9, 2004 | Abandoned |
Array
(
[id] => 7046078
[patent_doc_number] => 20050250673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-10
[patent_title] => 'Neurodegenerative disease treatment'
[patent_app_type] => utility
[patent_app_number] => 10/843209
[patent_app_country] => US
[patent_app_date] => 2004-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6855
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0250/20050250673.pdf
[firstpage_image] =>[orig_patent_app_number] => 10843209
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/843209 | Huntington's Disease Treatment | May 9, 2004 | Issued |
Array
(
[id] => 7371971
[patent_doc_number] => 20040219146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Prevention and treatment of amyloidogenic disease'
[patent_app_type] => new
[patent_app_number] => 10/828548
[patent_app_country] => US
[patent_app_date] => 2004-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 32499
[patent_no_of_claims] => 140
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20040219146.pdf
[firstpage_image] =>[orig_patent_app_number] => 10828548
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/828548 | Prevention and treatment of amyloidogenic disease | Apr 18, 2004 | Abandoned |